Proposal for the use in emergency departments of cardiac troponins measured with the latest generation methods in patients with suspected acute coronary syndrome without persistent ST-segment elevation

Clinical Chemistry and Laboratory Medicine

Volumn 51, Issue 9, 2013, Pages 1727-1737

  Casagranda, Ivo ^a   Cavazz, Mario ^b   Clerico, Aldo ^c   Galvani, Marcello ^d   Ottani, Filippo ^d   Zaninotto, Martina ^e   Biasucci, Luigi Maria ^f   Cervellin, Gianfranco ^g   Lenzi, Tiziano ^h   Lippi, Giuseppe ^g   Plebani, Mario ^e   Tubaro, Marco ⁱ  

^a Santi Antonio e Biagio and Cesare Arrigo Hospital   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c SCUOLA SUPERIORE SANT ANNA   (Italy)

^d MORGAGNI PIERANTONI HOSPITAL   (Italy)

^e UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^f CATHOLIC UNIVERSITY   (Italy)

^g ACADEMIC HOSPITAL OF PARMA   (Italy)

^h Emergency Department   (Italy)

ⁱ SAN FILIPPO NERI HOSPITAL   (Italy)

Author keywords

99th percentile; Acute coronary syndrome; Cardiac troponin; Emergency departments; High sensitivity assays; Non STsegment elevation

Indexed keywords

TROPONIN I; TROPONIN T;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; EMERGENCY WARD; EXERCISE TEST; FEMALE; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; MALE; PRIORITY JOURNAL; THORAX PAIN; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; AGE FACTORS; ANGINA, UNSTABLE; ELECTROCARDIOGRAPHY; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; SEX FACTORS; TROPONIN I; TROPONIN T;

EID: 84888113392     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2013-0423     Document Type: Article

References (63)

1. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36: 959-69.
2. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD: the Writing Group On behalf of the Joint ESC/ACCF/ AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. Circulation 2012;126: 2020-35.
3. Apple FS, Jesse RL, Newby LK, Wu AH, Christenson RH, Cannon CP, et al. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes. Clin Chem 2007;53: 547-51. (Pubitemid 46580222)
4. Thygesen K, Mair J, Katus H, Plebani M, Venge P, Collinson P, et al. Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J 2010;31: 2197-206.
5. Panteghini M, Pagani F, Yeo KT, Apple FS, Christenson RH, Dati F, et al. Committee on standardization of markers of cardiac damage of the IFCC. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin Chem 2004;50: 327-32. (Pubitemid 38156373)
6. Clerico A, Giannoni A, Prontera T, Giovannini S. High-sensitivity troponin: a new tool for pathophysiological investigation and clinical practice. Adv Clin Chem 2009;49: 1-30.
7. Apple FS. A new season for cardiac troponin assays: it's time to keep a scorecard. Clin Chem 2009;55: 1303-6.
8. Prontera C, Fortunato A, Storti S, Mercuri A, Longombardo G, Zucchelli GC, et al. Evaluation of analytical performance of the Siemens ADVIA TnI Ultra immunoassay. Clin Chem 2007;53: 1722-3. (Pubitemid 47340078)
9. Apple FS, Collinson PO. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem 2012;58: 54-61.
10. Franzini M, Prontera C, Masotti S, Zucchelli G, Storti S, Passino C, et al. Evaluation of analytical performance of a novel immunoenzymometric assay for cTnI. Clin Chim Acta 2013;416: 48-9.
11. Clerico A, Fortunato A, Prontera C, Ripoli A, Zucchelli GC, Emdin M. Distribution of plasma cardiac troponin I values in healthy subjects: pathophysiological considerations. Clin Chem Lab Med 2008;46: 804-8. (Pubitemid 351821637)
12. Venge P, Johnston N, Lindahal B, James S. Normal plasma levels of cardiac troponin I misurate by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia. J Am Coll Cardiol 2009;54: 1165-72.
13. Giannitis E, Kurz K, Hallermayer K, Jaraausch J, Jaffe AS. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem 2010;56: 254-61.
14. Saenger AK, Beyrau R, Braun S, Cooray R, Dolci A, Freidank H, et al. Multicenter analytical evaluation of a high-sensitivity troponin T assay. Clin Chim Acta 2011;412: 748-54.
15. Chang AM, Mumma B, Sease KL, Robey JL, Shofer FS, Hollander JE. Gender bias in cardiovascular testing persists after adjustment for presenting characteristics and cardiac risk. Acad Emerg Med 2007;14: 599-605. (Pubitemid 46920980)
16. Chandra A, Lindsell CJ, Limkakeng A, Diercks DB, Hoekstra JW, Hollander JE, et al. Emergency physician high pretest probability for acute coronary syndrome correlates with adverse cardiovascular outcomes. Acad Emerg Med 2009;16: 740-8.
17. Yates RB, Hestand BC. Effects of age, race, and sex on door-toelectrocardiogram time in emergency department non-ST elevation acute coronary syndrome patients. J Emerg Med 2011;40: 123-7.
18. Kaul P, Chang WC, Westerhout CM, Graham MM, Armstrong PW. Differences in admission rates and outcomes between men and women presenting to emergency departments with coronary syndromes. CMAJ 2007;177: 1193-9. (Pubitemid 350178608)
19. Panteghini M. Assay-related issues in the measurement of cardiac troponins. Clin Chim Acta 2009;402: 88-93.
20. Lippi G, Cervellin G, Aloe R, Montagnana M, Salvagno GL, Guidi GC. Non-commutability of results of highly sensitive troponin I and T immunoassays. Biochem Med (Zagreb) 2012;22: 127-9.
21. Wu AH, Lu QA, Todd J, Mooeks J, Wians F. Short- and long-term biological variation in cardiac troponin I measured with high-sensitivity assay: implications for clinical practice. Clin Chem 2009;55: 52-8.
22. Frankenstein L, Remppis A, Giannitis E, Frankenstein J, Hess G, Zdunek D, et al. Biological variation of high sensitive troponin T in stable heart failure patients with ischemic or dilated cardiomyopathy. Clin Res Cardiol 2011;100:633-40. References
23. Newby LK, Jesse RL, Babb JD, Christenson RH, De Fer TM, Diamond GA, et al. ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2012;60: 2427-63.
24. Haaf P, Drexler B, Reichlin T, Twerenbold R, Reiter M, Meissner J, et al. High-sensitivity cardiac troponin in the distinction of acute myocardial infarction from acute cardiac noncoronary artery disease. Circulation 2012;126: 31-4.
25. Grimes DA, Schulz KF. Refining clinical diagnosis with likelihood ratios. Lancet 2005;365: 1500-5. (Pubitemid 40591696)
26. Ottani F, Binetti N, Casagranda I, Cassin M, Cavazza M, Grifoni S, et al. Percorso di Valutazione del dolore toracico. Valutazione dei requisiti di base per i'implementazione negli ospedali italiani. G Ital Cardiol 2009;10: 46-63.
27. Diamond GA, Forrester JS. Analysis of probability as an aid to the clinical diagnosis of coronary artery disease. N Engl J Med 1979;300: 1350-8. (Pubitemid 9198112)
28. Braunwald E. Unstable angina. A classification. Circulation 1989;80: 410-4. (Pubitemid 19195751)
29. Diamond GA, Sanjay K. How would reverend Bayes interpret high-sensitivity troponin? Circulation 2010;121: 1172-5.
30. Stern S. Symptoms other than chest pain may be important in the diagnosis of "silent ischemia" or "the sound of silence". Circulation 2005;111:E435-7.
31. Briger D, Kim A, Goodman S, Steg PG, Budaij A, White K, et al. Acute coronary syndrome without chest pain, an underdiagnosed and undertreated high-risk group. Chest 2004;126: 461-9.
32. Sinclair D. Myocardial infarction. Consideration for geriatric patients. Can Fam Physicians 1994;40: 1172-7. (Pubitemid 24217189)
33. Canto JG, Shlipak MG, Rogers WJ, Malmgren JA, Frederick PD, Lambrew CT, et al. Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. J Am Med Assoc 2000;283: 3223-9. (Pubitemid 30422040)
34. Hammaad A, Lip GY, MacFachyen RJ. Acute coronary syndromes presenting solely with heart failure symptoms: are they under recognized? Eur J Heart Fail 2004;6: 683-6. (Pubitemid 39470220)
35. Stern S, Behar S, Leor J, Harpaz D, Boyko V, Gottlieb S. Presenting symptoms, admission electrocardiogram, management and prognosis in acute coronary syndromes: differences by age. Am J Geriatr Cardiol 2004;13: 188-96.
36. Tresch DD, Arrow WS. Clinical manifestations and diagnosis of coronary artery disease. Clin Geriatric Med 1966;12: 89-100.
37. Braunwald E. Examination of the patient: the history. In: Braunwald E, Zipes DP, Libby P, editors. Heart disease: a textbook of cardiovascular medicine. Philadelphia, PA: WB Saunders, 2001: 27-44.
38. American Diabetes Association. Consensus development conference on the diagnosis of coronary heart disease in people with diabetes. Diabetes Care 1998;21: 1551-9.
39. Moya A, Sutton R, Ammirati F, Blanc JJ, Brignole M, Dahm JB, et al. The Task Force for the diagnosis and management of syncope of the European Society of Cardiology. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J 2009;30: 2631-71.
40. Canto GJ, Goldberg RJ, Sopko G. A call to standardize symptom presentation in acute coronary syndromes. Am Heart J 2012;164: 801-6.
41. Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, et al. The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2011;32: 2999-3054. References
42. Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, et al. The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology. (ESC). The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology. Eur Heart J 2011;32: 2999-3054.
43. Thygensen K, Mair J, Giannitsis E, Mueller C, Lindahl B, Blankenberg S, et al. Study group on biomarkers in cardiology of the ESC working group on acute cardiac care. How to use high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J 2012;33: 2252-7.
44. Giannitsis E, Becker M, Kurz K, Hess G, Zdunek D, Katus HA. High-sensitivity cardiac troponin T for early prediction of evolving non-ST-segment elevation myocardial infarction in patients with acute coronary syndrome suspected and negative troponin results on admission. Clin Chem 2010;56: 642-50.
45. White DH. Higher sensitivity troponin levels in the community: what do they mean and how will the diagnosis of myocardial infarction be made? Am Heart 2010;159: 934-6.
46. Frankenstein L, Wu AH, Hallermayer K, Wians FH, Giannitsis E, Katus HA. Biological variation and reference change value of high-sensitivity troponin T in healthy individual during short and intermediate follow-up periods. Clin Chem 2011;57: 1068-71.
47. Wu AH, Lu QA, Todd J, Moecks J, Wians F. Short- and long-term biological variation in cardiac troponin I commensurate with a high-sensitivity assay: implications for clinical practice. Clin Chem 2009;55: 52-8.
48. Vasile VC, Saenger AK, Kroning JM, Klee GG, Jaffe AS. Biological variation of a novel cardiac troponin I assay. Clin Chem 2011;55: 1395-405.
49. Keller T, Zeller T, Ojeda F, Tzikas S, Lillpopp L, Sinning C, et al. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. J Am Med Assoc 2011;306: 2684-93.
50. Aldous SJ, Richards AM, Cullen L, Than MP. Early dynamic change in high-sensitivity cardiac troponin T in the investigation of acute myocardial infarction. Clin Chem 2011;57: 1154-60.
51. Apple FS, Perace LA, Smith SW, Kaczmarek JM, Murakami MA. Role of monitoring changes in sensitive cardiac troponin assay results for early diagnosis of myocardial infarction and prediction of risk of adverse events. Clin Chem 2009;55: 930-7.
52. Reichlin T, Irfan A, Twerenbold R, Reiter M, Hochholzer W, Burkhalter H, et al. Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction. Circulation 2011;124: 136-45.
53. Mueller M, Biener M, Vafaie M, Doerr S, Keller T, Blankenber S, et al. Absolute and relative kinetic changes of high-sensitivity cardiac troponin T in acute coronary syndrome and in patients with increased troponin in the absence of acute coronary syndrome. Clin Chem 2012;58: 209-18.
54. Kavsk PA, Allen LC, Apple FS, Booth RA, Chan PC, Delvin E, et al. Cardiac troponin testing in the acute care setting: ordering, reporting, and high sensitivity assays - an update from the Canadian Society of Clinical Chemists. Clin Biochem 2011;44: 1273-7.
55. Pretorius CJ, Wilgen U, Ungerer JP. Serial cardiac troponin differences commensurate on four contemporary analyzers: relative differences, actual differences and reference change values compared. Clin Chim Acta 2012;413: 1786-91.
56. Schreiber DH, Agbo C, Wu AH. Short-term (90 min) diagnostic performance for acute ST segment elevation non-myocardial infarction and 30-day prognostic evaluation of a novel thirdgeneration high sensitivity troponin I assay. Clin Biochem 2012;45: 1295-301.
57. Apple FS, Smith SW, Pearce LA, Murakami MM. Delta changes for optimizing clinical specificity and 60-day risk of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome utilizing the ADVIA Centaur TnI-Ultra assay. Clin Biochem 2012;45:711-3. References
58. The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology. Eur Heart J 2011;32: 2999-3054.
59. Braunwald E. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-elevation myocardial infarction. J Am Coll Cardiol 2000;36: 970-1062.
60. Keller T, Zeller T, Ojeda F, Tzikas S, Lillpopp L, Sinning C, et al. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. J Am Med Assoc 2011;306: 2684-93.
61. Body R, Carley S, McDowell G, Jaffe AS, France M, Cruickshank K, et al. Rapid exclusion of acute myocardial infarction in patients with undetectable troponing using high-sensitivity assay. J Am Coll Cardiol 2011;58: 1332-9.
62. Aldous S, Pemberton C, Richards AM, Troughton R, Than M. High-sensitivity troponin T for early rule-out of myocardial infarction in recent onset chest pain. Emerg Med J 2012;29: 805-10.
63. White HD. Higher sensitivity troponin levels in the community: what do they mean and how will the diagnosis of myocardial be made? Am Heart J 2010;159: 934-6.